Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 80 (RPL23AP80)

Target: RPL23AP80
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L23a pseudogene 80 (RPL23AP80) is classified as a pseudogene related to the functional ribosomal protein L23a gene. Pseudogenes are typically non-coding elements lacking protein-coding or regulatory function, and RPL23AP80 specifically is not known to produce a protein, affect signaling or cellular function directly, or serve as a therapeutic or diagnostic target. It is one of many ribosomal protein L23a pseudogenes scattered throughout the human genome, and current evidence does not support a role for RPL23AP80 in disease, cell signaling, or as a point of drug action[3][6].

Other names: RPL23A_35_1661RPL23AP80

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 80 (RPL23AP80).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 80 (RPL23AP80).

Explore the full profile